Phase Space AI

Bloom Energy Valuation 2026-07-28

Bloom Energy [BE]

Bloom Energy [BE] — Valuation, Factor Scorecard & Consensus Bridge

⚠️ SUPERSEDED IN PART — 2026-07-29

The position verdict in this document is retired. Under the current framework (references/criteria.md, 2026-07-29) the memo outputs an analysis, not a position. Whether an analysis justifies a position is a question about a particular book, and two books answer it differently.

The Gate block and the Gate 4 expected-return arithmetic below are also superseded, by the named Criteria (each with a type: BINDING or MEASURED, returning PASS / FAIL / INDETERMINATE), the reverse-DCF implied-path test, and a separate 12-month target.

→ Current analysis: Bloom_Energy_Criteria_and_Valuation_2026-07-29.md

Everything else here — the research, the evidence, the mechanism work — stands. Residual references to "Watchlist" in the prose below are the historical record of the 2026-07-28 assessment and are left intact deliberately.

Phase Space Research | July 28, 2026 | Tasks 3 of 9 | Skill v1.4.2

Companion to Bloom_Energy_Research_2026-07-28.md. Spot $183.90 aftermarket / $166.84 close on 2026-07-28, the day BE reported Q2 2026 after the bell.

---

5. FACTOR & ANOMALY SCORECARD

This is, on the factor evidence alone, the strongest long profile this system has underwritten — top-decile momentum, a large positive earnings surprise, a large upward guidance revision, and genuinely low accruals, in one name. The two offsets are real: +122.4% asset growth sits in the worst decile of an anomaly that works, and it is driven by an external capital raise (cash $606m → $2,667m), which is the bad kind of asset growth rather than the benign kind.

The momentum-crash caveat (Daniel & Moskowitz 2016)

12-1 momentum of +386% to +800% combined with 110% realised volatility and a price 37% below its own 50-day is the exact configuration in which momentum strategies crash. Daniel & Moskowitz show momentum's worst drawdowns cluster in high-volatility states following a trend break. The momentum reading is top-decile and maximally fragile. These are not in tension — they are the same fact.

---

6. VALUATION

At $183.90 (aftermarket) on 323.3m diluted shares: market cap $59.5bn. Cash $2,666.9m + restricted $21.6m against recourse debt $2,475.4m, non-recourse $2.6m and financing obligations $206.5m ⇒ net cash ≈ $4m, i.e. essentially zero. EV ≈ market cap.

6.1 Scenarios to FY2029E

Duration discipline per references/regime-change-test.md: the disclosed ~$6bn product backlog covers roughly 1.7 years of product revenue, so 2026–27 is modelled on the contracted base and 2028+ reverts.

Correction applied after Excel readback. A first pass used an 18% tax rate in the bull case and 21% elsewhere — a lower tax rate in the bull case double-counts optimism. All three scenarios now use 21%, which cut bull FY29 EPS from $7.64 to $7.37. Caught only by reading computed cells back out of the workbook, which is why that verification step exists. Conclusion unchanged.

6.2 Gate 4 on the CORRECTED basis (see the trade-construction memo §8)

The original version of this section was wrong. It discounted scenario payoffs at Ke and then compared the result to a 4.7% hurdle, which double-charges the required return. The identity is E[R]_reported = (E[R]_true − Ke)/(1+Ke), so every Ke column encoded the same expected return — the table had one degree of freedom presented as two, and its apparent "robustness across discount rates" was an artifact. Found by the memo-critic adversarial review at Task 5.5. Error: 15.0 percentage points a year, running in the name's favour.

Expected FY2029 value, probability-weighted: $126.60 against a $183.90 spot.

Fails at every bear weight including 0%. Break-even base exit multiple 40.1x, flat across Ke. Price at which E[R] equals the hurdle: $110.30.

6.3 Reverse-DCF — what $183.90 requires you to believe

Solving for the FY2029 revenue that justifies today's price, holding FY2029 non-GAAP operating margin at 24% (already ~3pts above FY2026E guidance):

The single most favourable defensible cell — a 50x exit multiple and a 12% cost of equity for a beta-3.1 stock — still requires revenue to compound ~30%/yr for three years on top of a year that itself doubles. Every other cell requires 40–77% CAGRs.

Base-rate check (Chan/Karceski/Lakonishok 2003): growth persistence beyond chance is not observable in the data; the frequency of firms above $2bn revenue sustaining >30% growth for a further three years after a >75% growth year is low single-digit percent. This does not say the bull case is wrong. It says the price already embeds it, and then some.

---

7. CONSENSUS BRIDGE

Numbers-vs-multiple decomposition — this is the crux. The house forecast is the Street forecast for FY2026; both are the company's guidance. There is no numbers disagreement at all. The entire $190+ gap between the $289.63 consensus target and the house value is the exit multiple and the discount rate. The Street is capitalising FY2027–28 earnings at 50–80x; the house is capitalising FY2029 earnings at 14–32x and discounting at 20.4%. To clear the hurdle the house would need a ~40x base-case exit multiple on FY2029 earnings.

That is a pure multiple disagreement, which is exactly the pattern calibration item B8 tracks — and it is now the fifth instance.

---